• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耳部器官参与利什曼原虫感染。

ENT involvement in Leishmania infections.

机构信息

Servicio de Otorrinolaringología, Hospital de Requena, Requena, Valencia, España.

Servicio de Otorrinolaringología, Hospital de Requena, Requena, Valencia, España.

出版信息

Acta Otorrinolaringol Esp (Engl Ed). 2021 Jan-Feb;72(1):3-10. doi: 10.1016/j.otorri.2019.11.006. Epub 2020 May 10.

DOI:10.1016/j.otorri.2019.11.006
PMID:32402379
Abstract

INTRODUCTION

Leishmaniasis comprises a group of diseases caused by protozoan parasites of the genus Leishmania that are transmitted by the bite of infected phlebotomine mosquitoes from animal reservoirs. Three different clinical forms are generated: cutaneous, mucocutaneous and visceral. We present the findings in the head and neck of this disease observed in our health area.

PATIENTS AND METHODS

A review of the last 26 years in our hospital, noting the clinical, diagnostic and therapeutic characteristics of the cases detected.

RESULTS

Thirteen cases were identified, 7 cutaneous, 4 mucocutaneous and 2 visceral or kala-azar. The mean age was 53.7±10.8 years. Immunodeficiency was identified in 61% of the cases. The incidence of the disease was 1.5:100,000 inhabitants/year, with a prevalence of 2%. Of those infected, 69% had involvement of the ear-nose-throat area. In 12 cases the diagnosis was established by biopsy of the lesions. The time from clinical debut to diagnosis ranged from 3 to 10 months. Antimony compounds were used as treatment in 11 patients and amphotericin B in 3, alone or combined with the former. One cutaneous form resolved with excision of the lesion. Ninety-two percent healed clinically and parasitologically.

CONCLUSIONS

Leishmaniasis in Spain frequently entails cutaneous and mucocutaneous involvement, often of the skin of the head, face and neck or upper-airway mucosa. Its clinical presentation varies greatly, and it should be suspected if there is no response to conventional therapies and in conditions of immunodeficiency.

摘要

简介

利什曼病是一组由利什曼原虫属的原生动物寄生虫引起的疾病,通过感染的白蛉从动物储库叮咬传播。产生三种不同的临床形式:皮肤、黏膜皮肤和内脏。我们在本卫生区观察到这种疾病在头颈部的发现。

患者和方法

回顾了我们医院过去 26 年的病例,记录了所发现病例的临床、诊断和治疗特征。

结果

共确定了 13 例病例,7 例皮肤型,4 例黏膜皮肤型,2 例内脏型或黑热病。平均年龄为 53.7±10.8 岁。61%的病例存在免疫缺陷。该疾病的发病率为 1.5:100,000 居民/年,患病率为 2%。感染者中,69%的人耳部、鼻部和喉部受累。12 例病例通过病变活检确立诊断。从临床发病到诊断的时间范围为 3 至 10 个月。11 例患者使用锑化合物治疗,3 例患者使用两性霉素 B 治疗,单独或联合使用上述药物。1 例皮肤型病例通过切除病变治愈。92%的患者临床和寄生虫学治愈。

结论

西班牙的利什曼病常涉及皮肤和黏膜皮肤,常累及头、面和颈部皮肤或上呼吸道黏膜。其临床表现差异很大,如果对常规治疗没有反应且存在免疫缺陷时,应怀疑该病。

相似文献

1
ENT involvement in Leishmania infections.耳部器官参与利什曼原虫感染。
Acta Otorrinolaringol Esp (Engl Ed). 2021 Jan-Feb;72(1):3-10. doi: 10.1016/j.otorri.2019.11.006. Epub 2020 May 10.
2
Cutaneous and Mucocutaneous Leishmaniasis.皮肤和黏膜皮肤利什曼病
Actas Dermosifiliogr (Engl Ed). 2021 May 11. doi: 10.1016/j.adengl.2021.05.011.
3
Ear, nose and throat manifestations of mucocutaneous Leishmaniasis: a literature review.黏膜皮肤利什曼病的耳、鼻和咽喉表现:文献综述
Acta Biomed. 2014 May 9;85(1):3-7.
4
Cutaneous and Mucocutaneous Leishmaniasis.皮肤和黏膜皮肤利什曼病
Actas Dermosifiliogr (Engl Ed). 2021 Feb 27. doi: 10.1016/j.ad.2021.02.008.
5
Leishmaniasis: recognition and management with a focus on the immunocompromised patient.利什曼病:以免疫功能低下患者为重点的识别与管理
Am J Clin Dermatol. 2002;3(2):91-105. doi: 10.2165/00128071-200203020-00003.
6
[Leishmania infantum/HIV co-infection: cutaneous lesions following treatment of visceral leishmaniasis].[婴儿利什曼原虫/艾滋病毒合并感染:内脏利什曼病治疗后的皮肤病变]
Ann Dermatol Venereol. 2006 Jan;133(1):39-42. doi: 10.1016/s0151-9638(06)70841-9.
7
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.一名接受免疫抑制治疗的患者出现内脏和黏膜皮肤利什曼病复发。
BMC Infect Dis. 2017 Jul 7;17(1):478. doi: 10.1186/s12879-017-2571-x.
8
Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.苏丹黏膜利什曼病:流行病学、临床特征、诊断、免疫反应及治疗
Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):647-52. doi: 10.1016/0035-9203(95)90428-x.
9
Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.抗肿瘤坏死因子诱发的内脏利什曼病和皮肤利什曼病:病例报告及文献综述
Dermatology. 2015;230(3):204-7. doi: 10.1159/000370238. Epub 2015 Jan 23.
10
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.合并感染HIV的利什曼病患者的皮肤利什曼病后皮肤黏膜病变及其他皮肤病变:与免疫反应相关的临床表现综述
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014.